On January 11, 2023 Leap Therapeutics, Inc. (Nasdaq: LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, reported that Douglas E. Onsi, President and Chief Executive Officer, Cynthia Sirard, MD, Chief Medical Officer, and Jason Baum, PhD., Vice President and Head of Translational Medicine will present a corporate overview at B. Riley Securities’ 3rd Annual Oncology Conference (Press release, Leap Therapeutics, JAN 11, 2023, View Sourcenews-releases/news-release-details/leap-therapeutics-present-b-riley-securities-3rd-annual-oncology" target="_blank" title="View Sourcenews-releases/news-release-details/leap-therapeutics-present-b-riley-securities-3rd-annual-oncology" rel="nofollow">View Source [SID1234626187]). The conference will be held in a virtual meeting format.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

LEAP PRESENTATION DETAILS:
B. Riley Securities’ 3rd Annual Oncology Conference
Date: Wednesday, January 18, 2022
Time: 1:30 p.m. Eastern Time

The presentation will be webcast live and may be accessed on the Investors page of the company’s website at View Source, where a replay of the event will also be available for a limited time.